[Form 4] PTC Therapeutics, Inc. Insider Trading Activity

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Analyzing...

Insights

Analyzing...

07/17/2025 - 05:20 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

#1946 Ranked by Market Cap

N/A Ranked by Dividends

PTCT Latest News

Jun 23, 2025

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

Jun 19, 2025

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 6, 2025

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

May 5, 2025

PTC518 PIVOT-HD Study Achieves Primary Endpoint

May 1, 2025

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTCT Latest SEC Filings

Jul 15, 2025

[144] PTC Therapeutics, Inc. SEC Filing

PTCT Stock Data

Market Cap 3.92B

Float 77.30M

Insiders Ownership 2.46%

Institutions Ownership 100%

Short Percent 4.8%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City WARREN

Trending News